94 related articles for article (PubMed ID: 15202502)
1. Construction, expression, and characterization of a recombinant annexin B1-low molecular weight urokinase chimera in Escherichia coli.
Yan HL; Wang WT; He Y; Zhao ZY; Gao YJ; Zhang Y; Sun SH
Acta Biochim Biophys Sin (Shanghai); 2004 Mar; 36(3):184-90. PubMed ID: 15202502
[TBL] [Abstract][Full Text] [Related]
2. Cloning, purification and biochemical characterization of a thrombus-ditargeting thrombolytic agent, comprised of annexin B1, ScuPA-32K and fibrin-adherent peptide.
Ding FX; Yan HL; Lu YM; Xue G; Mei Q; Huang JJ; Zhao ZY; Wang YZ; Sun SH
J Biotechnol; 2006 Nov; 126(3):394-405. PubMed ID: 16797768
[TBL] [Abstract][Full Text] [Related]
3. Design and characterization of a platelet-targeted plasminogen activator with enhanced thrombolytic and antithrombotic potency.
Yan HL; Sun SH; Wang WT; Ding FX; Mei Q; Xue G
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):115-25. PubMed ID: 16965265
[TBL] [Abstract][Full Text] [Related]
4. Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins.
Tait JF; Engelhardt S; Smith C; Fujikawa K
J Biol Chem; 1995 Sep; 270(37):21594-9. PubMed ID: 7665573
[TBL] [Abstract][Full Text] [Related]
5. Non-fusion expression in Escherichia coli, purification, and characterization of a novel Ca2+- and phospholipid-binding protein annexin B1.
Zhang Y; Guo YJ; Sun SH; Yan HL; He Y
Protein Expr Purif; 2004 Mar; 34(1):68-74. PubMed ID: 14766301
[TBL] [Abstract][Full Text] [Related]
6. A novel, cheap and effective fusion expression system for the production of recombinant proteins.
Ding FX; Yan HL; Mei Q; Xue G; Wang YZ; Gao YJ; Sun SH
Appl Microbiol Biotechnol; 2007 Nov; 77(2):483-8. PubMed ID: 17768617
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a recombinant chimeric plasminogen activator composed of Gly-Pro-Arg-Pro tetrapeptide and truncated urokinase-type plasminogen activator expressed in Escherichia coli.
Hua ZC; Chen XC; Dong C; Zhu DX
Biochem Biophys Res Commun; 1996 May; 222(2):576-83. PubMed ID: 8670247
[TBL] [Abstract][Full Text] [Related]
8. Soluble expression of a strong thrombolytic pro-urokinase mutant in Escherichia coli.
Lin J; Yang X; Deng R; Yu B; Lai H; Sun W; Wu W
Protein Expr Purif; 2006 Jul; 48(1):69-73. PubMed ID: 16503165
[TBL] [Abstract][Full Text] [Related]
9. Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets.
Wang X; Palasubramaniam J; Gkanatsas Y; Hohmann JD; Westein E; Kanojia R; Alt K; Huang D; Jia F; Ahrens I; Medcalf RL; Peter K; Hagemeyer CE
Circ Res; 2014 Mar; 114(7):1083-93. PubMed ID: 24508759
[TBL] [Abstract][Full Text] [Related]
10. Expression of an antibody-targeted plasminogen activator in Escherichia coli using chemically induced stress responses.
Yu M; Yu M; Ru B
Biotechnol Lett; 2004 Nov; 26(21):1629-34. PubMed ID: 15604810
[TBL] [Abstract][Full Text] [Related]
11. Production of biologically active recombinant annexin B1 with enhanced stability via a tagging system.
Zhang Y; Zheng T; Wang Y; Guo Y; Ding F; Fei M; Cui H; Sun S
Appl Microbiol Biotechnol; 2010 Jan; 85(3):605-14. PubMed ID: 19629475
[TBL] [Abstract][Full Text] [Related]
12. Secretory production of recombinant urokinase-type plasminogen activator-annexin V chimeras in Pichia pastoris.
Okabayashi K; Tsujikawa M; Morita M; Einaga K; Tanaka K; Tanabe T; Yamanouchi K; Hirama M; Tait JF; Fujikawa K
Gene; 1996 Oct; 177(1-2):69-76. PubMed ID: 8921847
[TBL] [Abstract][Full Text] [Related]
13. [Construction of fusion recombinant plasmid coding for RGD peptide and urokinase B chain, its expression in Escherichia coli and preliminary characterization of its biological activity].
Zhu FX; Xing GC; He FC
Sheng Wu Gong Cheng Xue Bao; 2000 Sep; 16(5):582-6. PubMed ID: 11191762
[TBL] [Abstract][Full Text] [Related]
14. Urokinase mutant with better fibrin-specificity.
Ma Z; Yu R; Hua Z; Zhu D
Sci China C Life Sci; 1996 Oct; 39(5):523-33. PubMed ID: 9772355
[TBL] [Abstract][Full Text] [Related]
15. Fusion expression of human pro-urokinase with E. coli thioredoxin.
Sun AL; Hua ZC; Yao J; Yang YH; Yin DQ
Biochem Mol Biol Int; 1998 Oct; 46(3):479-86. PubMed ID: 9818087
[TBL] [Abstract][Full Text] [Related]
16. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
Lijnen HR; Stump DC; Collen DC
Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
[No Abstract] [Full Text] [Related]
17. Renaturation, purification, and characterization of human plasminogen activator inhibitor type 2 (PAI-2) accumulated at high level in Escherichia coli.
Zhou A; Jiang X; Dou F; Zhu D; Xu X
J Biochem; 1997 May; 121(5):930-4. PubMed ID: 9192735
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterization of recombinant human micro-plasminogen.
Ma Z; Lu W; Wu S; Chen J; Sun Z; Liu JN
Biotechnol Lett; 2007 Apr; 29(4):517-23. PubMed ID: 17206368
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of trifunctional single-chain urokinase-type plasminogen activators.
Bi Q; Cen X; Huang Y; Zhu S
Eur J Biochem; 2002 Mar; 269(6):1708-13. PubMed ID: 11895441
[TBL] [Abstract][Full Text] [Related]
20. [The functional expression of humanized ScFv-urokinase fusion protein in Escherichia coli].
Liu ZG; Lin JB; Yuan XD; Kang TJ; Yu WY
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):509-11. PubMed ID: 12385254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
